Variant report

Variant	nsv1032559
Chromosome Location	chr5:167070888-167210684
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1258)
CpG islands
(count:673)
Chromatin interactive
region (count:10)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1258 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr5:167126403-167126862	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr5:167126325-167126946	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF3	chr5:167126323-167126896	A549	lung:	n/a	n/a
4	ATF3	chr5:167126373-167126898	A549	lung:	n/a	n/a
5	BACH1	chr5:167076826-167076884	K562	blood:	n/a	n/a
6	BACH1	chr5:167121337-167121547	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr5:167191723-167191731	H1-hESC	embryonic stem cell:	n/a	n/a
8	BCL11A	chr5:167126474-167126762	H1-hESC	embryonic stem cell:	n/a	n/a
9	BCL11A	chr5:167126436-167126790	H1-hESC	embryonic stem cell:	n/a	n/a
10	BCL3	chr5:167126255-167126932	A549	lung:	n/a	n/a
11	BCL3	chr5:167126229-167127053	A549	lung:	n/a	n/a
12	BHLHE40	chr5:167150308-167150646	A549	lung:	n/a	n/a
13	BHLHE40	chr5:167150252-167150696	HepG2	liver:	n/a	n/a
14	BHLHE40	chr5:167150214-167150694	K562	blood:	n/a	n/a
15	BHLHE40	chr5:167150271-167150685	GM12878	blood:	n/a	n/a
16	BRCA1	chr5:167150373-167150549	HepG2	liver:	n/a	n/a
17	BRCA1	chr5:167080881-167081369	Hela-S3	cervix:	n/a	n/a
18	BRCA1	chr5:167150328-167150625	Hela-S3	cervix:	n/a	n/a
19	BRCA1	chr5:167126419-167126913	Hela-S3	cervix:	n/a	n/a
20	BRCA1	chr5:167170812-167171094	Hela-S3	cervix:	n/a	n/a
21	BRCA1	chr5:167157168-167157512	Hela-S3	cervix:	n/a	n/a
22	CBX3	chr5:167126107-167126973	HCT-116	colon:	n/a	n/a
23	CBX3	chr5:167150287-167150615	K562	blood:	n/a	n/a
24	CBX3	chr5:167126261-167127010	HCT-116	colon:	n/a	n/a
25	CBX3	chr5:167105499-167105844	HCT-116	colon:	n/a	n/a
26	CEBPB	chr5:167153790-167153981	H1-hESC	embryonic stem cell:	n/a	n/a
27	CEBPB	chr5:167186552-167187010	A549	lung:	n/a	chr5:167186816-167186827
28	CEBPB	chr5:167170729-167171153	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr5:167157741-167158061	Hela-S3	cervix:	n/a	chr5:167157859-167157872
30	CEBPB	chr5:167080696-167081247	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr5:167080739-167081159	A549	lung:	n/a	n/a
32	CEBPB	chr5:167157074-167157527	Hela-S3	cervix:	n/a	chr5:167157385-167157393 chr5:167157255-167157268
33	CEBPB	chr5:167076137-167076359	HepG2	liver:	n/a	chr5:167076203-167076220
34	CEBPB	chr5:167071796-167071987	HepG2	liver:	n/a	n/a
35	CEBPB	chr5:167126113-167127010	HCT-116	colon:	n/a	n/a
36	CEBPB	chr5:167090160-167090522	A549	lung:	n/a	chr5:167090340-167090351
37	CEBPB	chr5:167126217-167127012	HCT-116	colon:	n/a	n/a
38	CEBPB	chr5:167179983-167180318	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr5:167079640-167080177	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr5:167150236-167150542	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr5:167126435-167126828	H1-hESC	embryonic stem cell:	n/a	n/a
42	CEBPB	chr5:167090159-167090538	IMR90	lung:	n/a	chr5:167090340-167090351
43	CEBPB	chr5:167090180-167090586	A549	lung:	n/a	chr5:167090340-167090351
44	CEBPB	chr5:167070129-167071209	Hela-S3	cervix:	n/a	n/a
45	CEBPB	chr5:167156962-167157604	A549	lung:	n/a	chr5:167157385-167157393 chr5:167157255-167157268
46	CEBPB	chr5:167165493-167165503	A549	lung:	n/a	n/a
47	CEBPB	chr5:167210636-167210822	IMR90	lung:	n/a	n/a
48	CEBPB	chr5:167157060-167157514	IMR90	lung:	n/a	chr5:167157385-167157393 chr5:167157255-167157268
49	CEBPB	chr5:167071732-167072033	IMR90	lung:	n/a	n/a
50	CEBPB	chr5:167186061-167186933	Hela-S3	cervix:	n/a	chr5:167186816-167186827

(count:673 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:167157137-167157187	HCPEpiC	choroid plexus:	n/a
2	chr5:167181519-167181569	HCPEpiC	choroid plexus:	n/a
3	chr5:167157137-167157187	HCPEpiC	choroid plexus:	n/a
4	chr5:167181519-167181569	HCPEpiC	choroid plexus:	n/a
5	chr5:167126705-167126755	AG10803	skin:	n/a
6	chr5:167142403-167142453	Hepatocyte	liver:	n/a
7	chr5:167181519-167181569	SKMC	muscle:	n/a
8	chr5:167192644-167192694	CMK	blood:	n/a
9	chr5:167142403-167142453	SK-N-MC	brain:	n/a
10	chr5:167157137-167157187	BE2_C	brain:	n/a
11	chr5:167088724-167088774	HPAEpiC	pulmonary alveolar:	n/a
12	chr5:167097366-167097416	HEEpiC	esophagus:	n/a
13	chr5:167181457-167181507	BE2_C	brain:	n/a
14	chr5:167171284-167171334	NH-A	brain:	n/a
15	chr5:167181457-167181507	CMK	blood:	n/a
16	chr5:167181762-167181812	ProgFib	skin:	n/a
17	chr5:167142403-167142453	HCPEpiC	choroid plexus:	n/a
18	chr5:167157137-167157187	AG04450	lung:	fetal
19	chr5:167171284-167171334	HCF	heart:	n/a
20	chr5:167097366-167097416	AG09309	skin:	n/a
21	chr5:167171284-167171334	SAEC	small airway:	n/a
22	chr5:167181457-167181507	HPAEpiC	pulmonary alveolar:	n/a
23	chr5:167157137-167157187	NHBE	bronchial:	n/a
24	chr5:167181519-167181569	GM12891	blood:	n/a
25	chr5:167181519-167181569	RPTEC	kidney:	n/a
26	chr5:167181836-167181886	MCF10A-Er-Src	breast:	n/a
27	chr5:167181457-167181507	Hela-S3	cervix:	n/a
28	chr5:167088724-167088774	GM12878	blood:	n/a
29	chr5:167126705-167126755	HepG2	liver:	n/a
30	chr5:167192644-167192694	BJ	skin:	n/a
31	chr5:167181457-167181507	HRCEpiC	kidney:	n/a
32	chr5:167157137-167157187	HNPCEpiC	eye:	n/a
33	chr5:167181519-167181569	Hela-S3	cervix:	n/a
34	chr5:167192644-167192694	HepG2	liver:	n/a
35	chr5:167181836-167181886	NT2-D1	testis:	n/a
36	chr5:167181519-167181569	HAEpiC	amniotic membrane:	n/a
37	chr5:167181457-167181507	HCT-116	colon:	n/a
38	chr5:167181762-167181812	A549	lung:	n/a
39	chr5:167181457-167181507	LNCaP	prostate:	n/a
40	chr5:167171284-167171334	AG04450	lung:	fetal
41	chr5:167192644-167192694	AG09309	skin:	n/a
42	chr5:167181762-167181812	Hela-S3	cervix:	n/a
43	chr5:167171284-167171334	K562	blood:	n/a
44	chr5:167126705-167126755	HRE	kidney:	n/a
45	chr5:167181762-167181812	ovcar-3	ovarian:	n/a
46	chr5:167171284-167171334	HAEpiC	amniotic membrane:	n/a
47	chr5:167171284-167171334	GM19239	blood:	n/a
48	chr5:167088724-167088774	HRCEpiC	kidney:	n/a
49	chr5:167171284-167171334	Caco-2	colon:	n/a
50	chr5:167126705-167126755	NHDF-neo	bronchial:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:167182573..167184424-chr5:167185880..167187597,2	MCF-7	breast:
2	chr5:167149950..167150478-chr5:167503586..167504419,2	MCF-7	breast:
3	chr5:167185874..167188275-chr5:167189453..167191702,2	K562	blood:
4	chr5:167149972..167151031-chr5:167474022..167475010,7	MCF-7	breast:
5	chr5:167185874..167188275-chr5:167189453..167191702,2	K562	blood:
6	chr5:167145648..167148194-chr5:167148598..167150135,2	MCF-7	breast:
7	chr5:167182573..167184424-chr5:167185880..167187597,2	MCF-7	breast:
8	chr5:167150201..167150713-chr5:167646626..167647567,2	MCF-7	breast:
9	chr5:167145648..167148194-chr5:167148598..167150135,2	MCF-7	breast:
10	chr5:167150041..167150634-chr5:167447492..167448418,3	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-WWC1-1	chr5:167148368-167148412	ENSG00000253357.1
2	lnc-PANK3-6	chr5:167087063-167087486	ENSG00000254187.1
3	lnc-WWC1-1	chr5:167155701-167156129	ENSG00000253357.1
4	lnc-PANK3-6	chr5:167080233-167080932	ENSG00000254187.1

No data

Variant related genes	Relation type
ENSG00000254187	TF binding region
TENM2	TF binding region
ENSG00000253357	TF binding region
ENSG00000254187	CpG island
TENM2	CpG island
ENSG00000253357	CpG island

Extended variants
information (count: 5247 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:5247 , 50 per page) page: 1 2 3 4 5 6 7 ... 105

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6881298	chr5:167070888-167070889	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs560622327	chr5:167070899-167070900	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs111612254	chr5:167070929-167070930	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs192122318	chr5:167070964-167070965	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs76104254	chr5:167070965-167070966	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs560067145	chr5:167071037-167071038	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs529055881	chr5:167071040-167071041	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs59004179	chr5:167071044-167071045	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs368714334	chr5:167071083-167071084	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs182367763	chr5:167071088-167071089	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs551360720	chr5:167071195-167071196	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs536512211	chr5:167071219-167071220	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs188160710	chr5:167071220-167071221	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs192690406	chr5:167071265-167071266	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs138158023	chr5:167071307-167071308	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs570090668	chr5:167071364-167071365	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs559669062	chr5:167071386-167071387	Enhancers Strong transcription Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs536821343	chr5:167071405-167071406	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs184482952	chr5:167071428-167071429	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs190545056	chr5:167071429-167071430	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs142015528	chr5:167071488-167071489	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs557769455	chr5:167071508-167071509	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs77337823	chr5:167071524-167071525	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs533575287	chr5:167071530-167071531	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs28691167	chr5:167071545-167071546	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs192433871	chr5:167071558-167071559	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs368045149	chr5:167071578-167071579	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs184980391	chr5:167071590-167071591	Strong transcription Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs145882600	chr5:167071602-167071603	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs542758547	chr5:167071603-167071604	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs370380044	chr5:167071666-167071667	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs562587213	chr5:167071715-167071716	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs575923177	chr5:167071737-167071738	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs148184740	chr5:167071758-167071759	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs564917977	chr5:167071764-167071765	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs527654285	chr5:167071850-167071851	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs547490362	chr5:167071852-167071853	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs188911905	chr5:167071864-167071865	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs530141777	chr5:167071880-167071881	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs550347523	chr5:167071884-167071885	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs570295734	chr5:167071910-167071911	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs539316854	chr5:167071911-167071912	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs552874990	chr5:167071942-167071943	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs570370442	chr5:167071953-167071954	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs566391389	chr5:167071978-167071979	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs113203246	chr5:167071993-167071994	Strong transcription Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs553489912	chr5:167072012-167072013	Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs573675983	chr5:167072048-167072049	Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs536006122	chr5:167072119-167072120	Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs78426604	chr5:167072123-167072124	Weak transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Breast cancer	17603634	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
severe myoclonic epilepsy of infancy	18294202	CNVD
Olfactory neuroblastoma	18408657	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mental retardation	17124404	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:1115 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:167065200-167071600	Enhancers	HSMM	muscle
2	chr5:167065600-167071600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
3	chr5:167065800-167071800	Enhancers	Osteobl	bone
4	chr5:167067000-167071200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
5	chr5:167067200-167084200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr5:167068200-167071600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr5:167069000-167072600	Enhancers	HMEC	breast
8	chr5:167069200-167072000	Enhancers	Hela-S3	cervix
9	chr5:167069200-167072000	Enhancers	NHDF-Ad	bronchial
10	chr5:167069200-167072200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr5:167069200-167072200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr5:167069200-167072600	Enhancers	NHEK	skin
13	chr5:167069400-167071600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr5:167069800-167071000	Enhancers	HUVEC	blood vessel
15	chr5:167069800-167071200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
16	chr5:167069800-167071400	Enhancers	ES-I3 Cell Line	embryonic stem cell
17	chr5:167069800-167071800	Enhancers	NHLF	lung
18	chr5:167069800-167072200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
19	chr5:167069800-167072400	Enhancers	A549	lung
20	chr5:167070000-167071400	Enhancers	NH-A	brain
21	chr5:167070000-167071600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
22	chr5:167070000-167072200	Enhancers	Muscle Satellite Cultured Cells	--
23	chr5:167070600-167071000	Weak transcription	HSMMtube	muscle
24	chr5:167070800-167072000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr5:167071000-167072000	Enhancers	HSMMtube	muscle
26	chr5:167071200-167072000	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr5:167071600-167071800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr5:167071600-167072200	Genic enhancers	HSMM	muscle
29	chr5:167071800-167072400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr5:167072000-167073800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
31	chr5:167072200-167072400	Enhancers	HSMM	muscle
32	chr5:167072400-167079000	Weak transcription	HSMM	muscle
33	chr5:167073800-167074200	ZNF genes & repeats	H9 Derived Neuron Cultured Cells	ES cell derived
34	chr5:167074200-167077400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr5:167076200-167077000	Enhancers	HUES48 Cell Line	embryonic stem cell
36	chr5:167076400-167077200	Enhancers	iPS-20b Cell Line	embryonic stem cell
37	chr5:167077400-167080000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr5:167078600-167079200	Weak transcription	NH-A	brain
39	chr5:167079000-167079600	Enhancers	Muscle Satellite Cultured Cells	--
40	chr5:167079000-167081000	Enhancers	NHDF-Ad	bronchial
41	chr5:167079000-167081400	Enhancers	HSMM	muscle
42	chr5:167079000-167081600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr5:167079000-167081600	Enhancers	Osteobl	bone
44	chr5:167079200-167079400	Enhancers	NH-A	brain
45	chr5:167079200-167081600	Enhancers	Hela-S3	cervix
46	chr5:167079400-167079600	Enhancers	A549	lung
47	chr5:167079400-167079800	Flanking Active TSS	NH-A	brain
48	chr5:167079400-167080400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr5:167079400-167081400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
50	chr5:167079400-167081400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links